About

Brand Overview

A high-quality nutritional supplement research and development, production, sales, and service enterprise originating from the United States and renowned worldwide, founded by biologist Dr. Peter Higgs in 1966.

About Rothschild Gene Corp.

Rothschild Gene， A high-quality nutritional supplement research and development, production, sales, and service enterprise originating from the United States and renowned worldwide, founded by biologist Dr. Peter Higgs in 1966. The brand name is inspired by the famous Rothschild family in Europe, symbolizing wealth, wisdom, and heritage, implying that Rothschild Gene will bring the most precious health wealth to global consumers. As a leader in the field of health and nutrition, Rothschild Gene focuses on providing a range of scientifically validated, naturally pure, and highly effective dietary supplements to consumers worldwide. Its footprint has spread to over 21 countries and regions including Europe, Asia, and North America, with annual sales exceeding $2 billion.

Brand Development History

1966: Legendary Voyage
Dr. Peter Higgs achieved breakthrough results in molecular biology research at the University School of Medicine, revealing the mysteries of human genetic makeup and laying the foundation for advances in nutrition and health sciences. Inspired by this, he founded Rothschild Gene, aiming to combine the wisdom of genetics with the power of biotechnology to bring scientific health solutions to global consumers.
1968: Equal emphasis on scientific research and production
Rothschild Gene established its first professional laboratory in Long Island, New York, and subsequently set up a modern and intelligent production factory in Colorado, comprehensively enhancing its product research and development capabilities and production level, laying a solid foundation for the rapid development of the brand.
1975: The first batch of products were launched
Based on the latest achievements in genetic research and biotechnology, Rothschild Gene has launched its first batch of nutritional supplement products and achieved great success in the US market. These products have won widespread praise from consumers for their excellent quality and significant health benefits.
1978: Technological Innovation
Rothschild Gene has successfully developed advanced biological purification technology, marking a significant breakthrough for the brand in the field of health technology. The application of this technology has enabled Rothschild Gene's products to reach industry-leading levels in quality, safety, and efficacy.
1982: The Brilliance of the European Market
Rothschild Gene's first foray into the European market quickly gained widespread attention and recognition. This move not only promotes the popularization of dietary supplements in Europe, but also further consolidates Rothschild Gene's leading position in the global health field.
2003: The Rise of the Asian Market
Rothschild Gene officially entered the Asian market and quickly became an important force in the Asian nutritional supplement market with advanced health concepts and technological capabilities. The brand customizes products to meet the specific needs of Asian consumers and has received widespread praise.
2010: Leader in the online market
Rothschild Gene, with its strong brand influence and excellent product quality, has taken a leading position on online e-commerce platforms in the European market. Its nutritional supplement products have become a hot selling category across the internet, winning the trust and love of a large number of consumers.
2020: Building a Big Health Ecosystem
Rothschild Gene collaborates with major global research institutions and health industry companies to build a comprehensive health ecosystem. Through cross disciplinary cooperation, the brand has further expanded its health industry map and is committed to promoting the sustainable development of the global health industry.
2024: Major Cooperation
In 2024, Harvard Gene Corp. reached a significant cooperation agreement between China Resources Group and North American Pharmaceutical Co., Ltd., successfully signing an exclusive omnichannel distributor agreement in Asia. This milestone collaboration undoubtedly opens up a new chapter for Harvard Genomics' layout in the Asian market. With the advanced pharmaceutical concepts and technical support of North American Pharmaceutical Co., Ltd., Harvard Genomics is expected to rapidly expand its market share in Asia and provide high-quality gene related products and services to a wider range of regions in Asia. This collaboration is not accidental. In recent years, the demand for genetic technology related products and services in Asia has shown explosive growth, with enormous market potential. Harvard Genomics has keenly captured this market trend, and through its strong alliance with North American Pharmaceutical Co., Ltd., it can not only fully leverage the advantages of all parties and achieve optimized integration of resources, but also inject new vitality into the medical and health industry in Asia, promoting the popularization and application of genetic technology to new heights in the region.

Mission & Vision

Rothschild Gene has always adhered to the core concept of "technology leads the future of health" and is committed to promoting the development of global health through technological innovation. The brand vision is to become a leader in the global field of biological science nutrition supplementation, safeguard life with technology, and set a new benchmark for human health.

Rothschild Gene strives to provide precise and effective nutritional support to every consumer worldwide through continuous optimization of product quality and services, helping them maintain health, delay aging, and enhance vitality. The mission of the brand is to "professionally refine every step, strive for excellence in technology, and provide high-quality services to global customers". Through continuous optimization of production processes and technology, we ensure that every product can meet consumer needs to the greatest extent possible.

Company Qualification

Rothschild Gene has received multiple authoritative certifications, including FDA (US Food and Drug Administration), cGMP (US Food and Drug Administration Certification), NSF (National Health Foundation), SGS (internationally recognized testing, inspection, and certification body), HACCP (Hazard Analysis and Critical Control Points), HALAL (Halal Certification), and ISO (International Organization for Standardization). These certifications not only demonstrate Rothschild Gene's outstanding performance in product quality, production management, and food safety, but also provide strong guarantees for its expansion in the global market.